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Body-focused repetitive behavior disorders (BFRBs) include Trichotillomania (TTM; Hair pulling disorder) and
Excoriation (Skin Picking) Disorder (SPD). These conditions are prevalent, highly heterogeneous, underresearched, and under-treated. In order for progress to be made in optimally classifying and treating these
conditions, it is necessary to identify meaningful subtypes. 279 adults (100 with TTM, 81 with SPD, 40 with both
TTM and SPD, and 58 controls) were recruited for an international, multi-center between-group comparison
using mixture modeling, with stringent correction for multiple comparisons. The main outcome measure was to
examine distinct subtypes (aka latent classes) across all study participants using item-level data from goldstandard instruments assessing detailed clinical measures. Mixture models identified 3 subtypes of TTM (en
tropy 0.98) and 2 subtypes of SPD (entropy 0.99) independent of the control group. Significant differences
between these classes were identified on measures of disability, automatic and focused symptoms, perfectionism,
trait impulsiveness, and inattention and hyperactivity. These data indicate the existence of three separate sub
types of TTM, and two separate subtypes of SPD, which are distinct from controls. The identified clinical dif
ferences between these latent classes may be useful to tailor future treatments by focusing on particular traits.
Future work should examine whether these latent subtypes relate to treatment outcomes, or particular psy
chobiological findings using neuroimaging techniques.

1. Introduction

impairment in physical, social, and psychological domains, and they
may exact an enormous personal and societal cost (Tucker et al., 2011;
Walther et al., 2014). Both psychosocial and psychopharmacological
treatments have demonstrated some degree of efficacy; however, many
individuals fail to respond or exhibit only partial response to these in
terventions (Lee et al., 2019; Sani et al., 2019). Relapse is common over
the long-term and remission is unusual (Franklin et al., 2011).

Trichotillomania (TTM) and Excoriation (Skin Picking) Disorder
(SPD), are characterized by repeated pulling out of one’s hair resulting
in hair loss and picking at one’s skin resulting in tissue damage,
respectively, and have been conceptualized as body focused repetitive
behavior disorders (BFRBs). BFRBs often result in significant
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One issue that has hampered treatment development to date is that
the understanding of the phenomenology and pathophysiology of BFRBs
remains limited by the relatively small samples enrolled in most clinical
studies. Existing literature suggests environmental and internal factors,
including boredom, activity restriction, emotional reactivity, stress
response, abnormalities in perceptual sensitivity, dissociation, and
trauma history may all contribute to symptom provocation and exac
erbation of BFRBs (for a review (Snorrason et al., 2012)). Both disorders
are familial, and twin studies have demonstrated significant shared ge
netic risk between TTM and SPD, as well as shared heritability with
obsessive-compulsive spectrum disorders more broadly (Monzani et al.,
2014).
In terms of neurocognitive processing and brain networks in BFRBs,
the literature reveals mixed findings from neurocognitive examinations
designed to assess motor inhibition, spatial working memory, divided
attention, visuo-spatial learning, and cognitive flexibility (Chamberlain
et al., 2009; Snorrason et al., 2011; Francazio and Flessner, 2015).
Furthermore, BFRB research comparing patients to matched controls
has identified abnormalities in multiple brain regions underpinning
many of the above neurocognitive domains. In small samples of par
ticipants (Ns ranging from 10 to 76), there has been evidence for ab
normalities in multiple brain regions, including those regions involved
in habit learning (e.g., striatum), emotion regulation (e.g., amygda
lo–hippocampal complex), memory processing (e.g., temporal lobe),
self-monitoring and awareness (e.g., precuneus), reward processing (e.
g., ventral striatum, frontal hemisphere, bilateral cuneus), visual pro
cessing of disgust (e.g., insula and putamen), and the ability to generate
and suppress motor responses (e.g., several cortical areas, including the
right frontal gyrus) (Chamberlain et al., 2009; Flessner et al., 2012;
Chamberlain et al., 2018; Isobe et al., 2018).
These varied findings from phenomenological, cognitive, and
neurobiological studies, as well as inconsistent results from psychosocial
and pharmacological interventions (Franklin et al., 2011; Rothbart
et al., 2013), suggest heterogeneity within these disorders. In fact, for
years, clinical studies have attempted to parse the possible etiological
and phenotypic heterogeneity in TTM and SPD based on a variety of
parameters such as sex, pulling/picking style, pulling/picking triggers,
age of onset, co-occurring mental health disorders, family history, affect
regulation and emotional cues (Flessner et al., 2013; Pozza et al., 2016;
Lochner et al., 2019; Ricketts et al., 2019). These findings, however,
have been undermined by relatively small sample sizes and inconsistent
findings, and integrated models of disease pathology have yet to emerge.
The result is that there remains a substantive need for further work
aimed at understanding the clinical, biological, and neurocognitive
underpinnings of BFRBs.
A deeper understanding of phenotypic heterogeneity should improve
efforts to clarify BFRB pathophysiology by identifying more homoge
neous BFRB-related latent phenotypes. Mixture modeling (MM) is a type
of statistical methodology combining latent profile analysis and latent
class analysis that has been widely used to identify candidate subtypes of
a variety of mental disorders, including eating disorders, depression, and
post-traumatic stress disorder (Wade et al., 2006; Hansen et al., 2017).
Essentially, MM identifies separable groups of individuals differentiated
by values on an unobserved latent variable, constructed from multiple
measured variables. The use of MM statistical approaches to identify
subgroups of people with BFRBs based on patterns of symptom expres
sion can provide evidence of novel phenotypic subtypes that may reflect
the underlying neurocircuitry of these behaviors. This approach, in turn,
should allow for improved prevention and treatment strategies tailored
to the needs of individual profiles (Collins and Varmus, 2015). Thus, the
objective of this study was to identify and characterize distinct latent
subtypes of TTM and SPD among a large well characterized sample of
diagnosed adults.

2. Materials and methods
Participants included 279 adults recruited from the community and
identified as having either a BFRB (meeting DSM-5 criteria for TTM,
SPD, or both as their primary psychiatric problem; if a person had DSM-5
TTM and some skin picking that did not meet full diagnostic criteria for
SPD, they would be classified as having only TTM) or being a healthy
control. Four sites were involved in recruitment: University of Chicago,
University of California, Los Angeles, Massachusetts General Hospital/
Harvard Medical School, and Stellenbosch University. Recruitment
started in October 2017 and ended in March 2019.
Inclusion criteria for the clinical sample were: a) DSM-5 diagnosis of
TTM and/or SPD; b) aged 18–65 years; c) fluency in English; and d)
capable of providing informed consent. Inclusion criteria for the healthy
controls were the same except they could have no current or lifetime
history of any DSM-5 psychiatric disorder.
Exclusion criteria for the clinical sample and healthy controls were:
(a) current or lifetime diagnosis of any serious medical or psychiatric
illness that would preclude successful study participation (e.g., psy
chotic disorder, intellectual disability); (b) neurological conditions that
would preclude completion of neurocognitive tasks; (c) use of psycho
tropic medications unless the dose had been stable for at least the past 3
months; (d) body metal other than dental fillings (assessed using a
neuroimaging screening form) (this was because all participants were
only enrolled at the US sites if they were also able to undergo neuro
imaging); (e) positive pregnancy test for females of childbearing age;
and (f) medical condition or other factor (e.g., vision or hearing prob
lems) that would interfere in the subject’s ability to participate in the
study.
2.1. Procedures
Potential participants were screened by the study site coordinator,
who then scheduled an interview date. On the day of the assessment,
participants met with study staff to complete informed consent. They
were given an opportunity to ask questions and were reminded that
study participation was voluntary. The primary investigator and/or
trained study personnel discussed potential risks of the study prior to
obtaining informed consent. After receiving a complete description of
the study, participants provided written informed consent. Participants
received a cash incentive for participation to reimburse them for their
time and transport costs.
The authors assert that all procedures contributing to this work
comply with the ethical standards of the relevant national and institu
tional committees on human experimentation and with the Helsinki
Declaration of 1975, as revised in 2008. All procedures involving human
subjects were approved by the Institutional Review Boards at each of the
participating universities. Data sharing agreements were arranged
across all sites.
2.2. Assessments
All participants completed a comprehensive diagnostic interview
(Mini International Neuropsychiatric Interview 7.0 (MINI 7.0) (Sheehan
et al., 1998); BFRB diagnostic modules and symptom severity scales,
which were completed by trained diagnosticians with a bachelor’s de
gree or higher trained to reliability and supervised by a doctoral-level
clinician; neurocognitive tasks from the Cambridge Neurocognitive
Test Automated Battery (CANTAB; http://www.cantab.com), which
were counter-balanced; and self-report questionnaires regarding BFRB
symptoms, general psychopathology, quality of life, and family envi
ronment completed at home via a web link through Research electronic
data capture (REDCap)(Harris et al., 2009). A detailed list of the as
sessments is provided in the Supplement. The total assessment time was
approximately 4–5 h. Study participation could be divided into two
visits scheduled across two consecutive days (no more than 14 days
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between visits), with breaks permitted if needed.

Barratt Impulsivity Scale (BIS-11, total score) (Patton et al., 1995),
extra-dimensional set-shifting errors (CANTAB IED) (Owen et al., 1991),
and stop-signal reaction times (CANTAB SSRT) (Aron et al., 2007). The
above-mentioned family history assessments were made in first-degree
relatives by the probands; relatives were not interviewed. In each
case, symptoms were differentiated from an actual diagnosis made by a
treatment provider, and for purposes of this study, a diagnosis was only
entered as positive if the family member had been formally diagnosed.
These predictors of interest were added separately, one at a time and
the corresponding p-values were corrected for multiple testing using the
Holm-Bonferroni method. Mixture modeling (including models with
predictors) was conducted using MPlus 8.4 (Muthén and Muthén, 2016),
and data were further processed in R (R Core Team, 2002).

2.3. Quality assurance
Drawing on approaches used in other research where the integrity of
diagnostic conclusions has been paramount and where there have been
multiple domains of assessment, we tracked diagnostic assessment and
clinical interview procedures; adherence to imaging and neurocognitive
protocols; and adverse event prevention and response. Protocol fidelity
monitoring was addressed by several mechanisms including written
guidelines, monitoring forms, on-site supervision, and cross-site calls.
Each site was led by an investigator with extensive clinical and research
expertise in BFRBs. Cross-site panels monitored caseness. Ongoing
monitoring took place via team meetings at each site weekly and crosssite teleconferences conducted regularly. Among other things, the crosssite calls were used to review interviews, and in the instance of diag
nostic disagreement, the sources of these differences were discussed and
a consensus diagnosis was reached.

3. Results
3.1. Sample characteristics
The final sample included 279 participants (221 with a BFRB and 58
healthy controls), of which 100 had TTM (83.0% female; mean age =
30.8 ± 9.7), 81 had SPD (88.9% female; mean age = 32.4 ± 11.3), and
40 had both TTM and SPD (87.5% female; mean age = 27.0 ± 8.1)(i.e.
met full DSM-5 diagnostic criteria for both disorders). Of the 58 healthy
controls, 45 (77.6%) were female and the mean age was 29.2 ± 11.2
years. Demographic data of those participants with BFRBs at each site is
presented in Table 1.

2.4. Data analysis
Mixture modeling (MM) was used to identify a number of homoge
neous, distinct subtypes (aka classes) across all study participants. To
identify TTM subtypes, we used item-level data of the 13-item Mil
waukee Inventory for Subtypes of Trichotillomania (MIST-A-R)(Keuthen
et al., 2015), which assesses intentionality and emotionality, combined
with item-level data from the Massachusetts General Hospital Hair
Pulling Scale (MGH-HPS) (Keuthen et al., 2005), a 7-item severity scale
assessing urges and resistance. To identify SPD subtypes, we used
item-level data of the 12-item MIDAS (Milwaukee Inventory for the
Dimensions of Skin Picking) (Walther et al., 2009), which assesses
automatic and focused picking styles, combined with item-level data
from the 8-item Skin Picking Scale-Revised (SPS-R) (Snorrason et al.,
2012), a scale of severity based on urge and resistance. Each measure
used has excellent psychometric properties. After several online meet
ings consensus was reached amongst international experts of BFRBs that
these MM input variables were most reflective of the core validated
symptoms of each disorder. We also ran sensitivity analysis where we
estimated MM models (without predictors) for only clinical cases (see
Supplement).
Maximum likelihood estimation with 100 random starts was used to
minimize the risk of finding local maxima. We tested models with up to
six classes. Selection of the optimal model was based on Bayesian In
formation Criteria (BIC) (Akaike, 1974; Schwarz, 1978) (we report both
Akaike’s Information Criterion (AIC) and BIC but used BIC for decision
on number of classes) and classification entropy. Individuals were
allocated into classes based on the largest probability (maximum a
posteriori, MAP).
Once meaningful and reliable subtypes were identified based on
symptom scales, we included predictors of latent classes as auxiliary
variables in the mixture models (using a 3-step-approach (http://www.
statmodel.com/download/webnotes/webnote15.pdf,Asparouhov and
Muthén, 2014)) to assess the distribution and prevalence of comorbid
ities (and neurocognitive functions) across subtypes. We considered the
following measures (disorders) as predictors of latent classes: Emotion
Regulation Questionnaire - Reappraisal and Suppression subscales
(Gross and John, 2003); Distress Tolerance Scale total score (Simons and
Gaher, 2005); Adult Sensory Profile: Sensory Sensitivity subscale
(Brown, 2002); age; gender; duration of illness; presence of ADHD
(threshold for probable caseness on the Adult ADHD Self-Report Scale
Screener (Kessler et al., 2005)), presence of obsessive compulsive dis
order (OCD) (MINI diagnosis), family history of alcohol or substance use
disorder, family history of OCD, psychosocial disability (Sheehan
Disability Scale) (Sheehan et al., 1996), Short Mood and Feelings
Questionnaire (total scores, depression) (Angold et al., 1995), perfec
tionism (Frost perfectionism scale total score) (Frost et al., 1990);

3.2. Identification of subtypes
Fit parameters for the models from mixture models are outlined in
Tables 2a and Table 2b (for additional statistical details see Supple
ment). For the TTM subtype analysis, the BIC data suggested that a 4class model was the best fitting model statistically. Entropy of the
final 4-class model was 0.98, indicating excellent class separation (en
tropy is a measure of reliability of classification and indication of sep
aration of classes, and ranges from 0 to 1, with higher values indicating
better class separation and more reliable classification of individuals
into corresponding classes). For the SPD subtype analysis, the BIC data
suggested that a 3-class model was the best fitting model statistically.
Entropy of the final 3-class model was 0.99, indicating excellent class
separation.
Figs. 1 and 2 show the profiles of the identified classes. In terms of
TTM, Class 1 (n = 121) had no TTM cases, and was defined as the TTMabsent group. There were essentially 3 latent subtypes of TTM, which we
refer to as Subtypes 1, 2, and 3. Subtype 1 (n = 27) is characterized by
the following: highly focused pulling, but low frequency and intensity of
urges to pull, and lower frequency of pulling behavior. Subtype 2 (n =
81) is characterized by automatic pulling with fairly low urges to pull
but report pulling due to emotional triggers. The unique characteristics
of Subtype 3 (n = 50) are that they pull largely to control unpleasant
feelings and feel generally unable to resist their pulling.
In terms of SPD, Class 1 (n = 115) had no SPD cases, and was defined
as the SPD-absent group. There were essentially 2 latent subtypes of
SPD, which we refer to as Subtypes 1 and 2. Subtype 1 (n = 112) is
characterized by strong and frequent urges to pick, picking both from
negative emotions as well as automatic picking, and reporting little
control. Subtype 2 (n = 52) comprises a group of people with milder SPD
symptoms as they report low urges to pick, not picking due to emotional
issues, spending less time picking, and reporting little distress or impact
from the picking.
3.3. Differences between the latent class subtypes on variables of interest
Each latent subtype of TTM was compared on a number of variables
to characterize the subtypes clinically (see Table 3). This was also per
formed on each latent subtype of SPD (see Table 4).
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Table 1
Demographic data for the 279 adults participants based on study site.

Females, n (%)
Mean Age (SD)
Trichotillomania, n (%)
Skin Picking Disorder, n (%)
Comorbid trichotillomania plus skin
picking disorder, n (%)
Controls, n (%)

University of Chicago
(n = 93)

University of California, Los
Angeles (n = 87)

Massachusetts General Hospital/Harvard
Medical School (n = 84)

Stellenbosch University
(n = 15)

77 [83.7%]
30.1 (8.5)
37 [40.0%]
32 [34.4%]
10 [10.8%]

67 [77.9%]
29.8 (10.4)
33 [37.9%]
17 [19.5%]
16 [18.4%]

65 [77.4%]
30.5 (11.4)
17 [20.4%]
32 [38.1%]
12 [14.3%]

14 [93.3%]
34.9 (15.8)
13 [86.7%]
0 [0%]
2 [13.3%]

14 [15.1%]

21 [24.1%]

23 [27.4%]

0 [0%]

unique clinical characteristics of the various subtypes that potentially
could be targets for treatment.

Table 2a
Summary of model fit parameters from Mixture Modeling Analysis.
Trichotillomania subtypes based on combined item-level data from MGH-HPS
and MIST-A-R.
Title

Observations

Parameters

AIC

BIC

Entropy

1-classes;
2-classes;
3-classes;
4-classes;
5-classes;
6-classes;

279
279
279
279
279
279

54
96
138
180
222
264

22635
18043
17540
17213
17104
17068

22831
18392
18042
17868
17911
18027

NA
0.999
0.976
0.980
0.980
0.975

4.1. Differences between the TTM subtypes
Our results suggest that TTM has three subtypes with unique clinical
presentations. Of the three subtypes of TTM, Subtype 1 (which we refer
to as “sensory sensitive pullers”) is characterized by highly focused
pulling, but urges to pull are generally infrequent and of low intensity.
Thus this group has a somewhat lower frequency of pulling behavior. A
person in this subtype scores high on measures of sensory sensitivity, is
moderately impaired by their pulling, and reports moderate mood
symptoms.
A person in Subtype 2 (which we refer to as “low awareness pullers”),
the most common subtype (54.2% of TTM participants), reports more
automatic pulling, and more pulling due to emotional triggers, with
fairly low urges to pull. This person may report some impairment and
some mood issues but unlike Subtype 1, they may present with some
ADHD symptoms and higher levels of overall impulsivity.
A person in Subtype 3 (which we refer to as “impulsive/perfectionist
pullers”) may present with the most unique characteristics of the three
groups. These are generally people who pull to control unpleasant
feelings and feel generally unable to resist their pulling. They report a
greater degree of impairment and mood symptoms, and less distress
tolerance than controls or the other subtypes of TTM. They are simul
taneously more likely to score higher on measures of perfectionism than
the other subtypes, and also score very high on measures of overall
impulsivity.

Table 2b
Skin Picking Disorder subtypes based on combined item-level data from MIDAS
and SPS-R.
Title

Observations

Parameters

AIC

BIC

Entropy

1-classes;
2-classes;
3-classes;
4-classes;
5-classes;
6-classes;

279
279
279
279
279
279

54
96
138
180
222
264

13761
9943
9478
9310
9249
9261

14048
10521
10347
10469
10699
11002

NA
0.999
0.985
0.986
0.989
0.990

Abbreviations: MGH-HPS = Massachusetts General Hospital Hair Pulling Scale;
MIST-A-R = Milwaukee Inventory for Subtypes of Trichotillomania-AdultRevised; MIDAS = Milwaukee Inventory for the Dimensions of Adult Skin
Picking; SPS-R=Skin Picking Scale-Revised.

In terms of the TTM subtypes, Subtype 1 scored highest in sensory
sensitivity and had significantly elevated scores compared to controls on
impairment and mood symptoms (Table 3). Subtype 2 is notable for
some of the same problems of Subtype 1 (mood and impairment issues)
but also ADHD symptoms and general impulsivity as seen on the BIS-11.
Subtype 3 is perhaps the most striking latent class as it has the same
symptoms of the other subtypes (but to a greater degree of impairment
and mood symptoms) and additionally scored high on perfectionism,
had less distress tolerance, and scored highest on impulsivity (Table 3).
In terms of the SPD subtypes, Subtype 1 had significantly more
ADHD symptoms, co-occurring ADHD diagnoses, more impairment and
more mood symptoms than the controls or the other latent class
(Table 4). Unique to this subtype was high levels of perfectionism and
less distress tolerance. Subtype 2 reported some ADHD symptoms rela
tive to controls, some problems with sensory sensitivity relative to
controls, poor distress tolerance, but impairment at the same level of
controls and no problems with perfectionism.

4.2. Differences between the SPD subtypes
The two SPD subtypes also exhibited clinical differences from each
other. Of the two subtypes of SPD, Subtype 1 (which we refer to
“emotional/reward pickers”) which represents the majority of people
with SPD is characterized by strong and frequent urges to pick, picking
from negative emotions as well as automatic picking, and reporting little
control. People in this subtype score high on measures of ADHD and
report high levels of perfectionism.
Subtype 2 (which we refer to as “functional pickers”) reflects a group
of people with fairly mild SPD, with lower urges to pick, and overall
little distress or impact from the picking. Interestingly, these people
report some problems with sensory sensitivity and poor distress toler
ance. They report minimal impairment due to their picking and do not
present problems with emotional dysregulation, perfectionism or
impulsivity.
The subtypes of SPD are a bit more problematic than those for TTM.
Are these two subtypes truly categorically different, or, might they
simply be different ends of a continuum? Considering the move toward
dimensional conceptualizations and the lack of robust distinguishing
characteristics here, these two subtypes may be reflective of a mild vs
more moderate-severe symptomatology, rather than “subtypes”. Future
research should examine whether these "subtypes" change over time
with treatment as their symptoms improve.

4. Discussion
To our knowledge, this is the largest phenotyping study of BFRBs
using multimodal, gold standard assessment tools. This paper makes
several important contributions to our understanding of BFRBs. First,
instead of being simply homogeneous disorders, mixture modelling
(MM) indicated that both TTM and SPD are comprised of separate
subtypes, three in the case of TTM and two for SPD. Second, there are
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Fig. 1. Profiles of latent subtypes on the MIST-A-R (Top graph; all latent subtypes combined), and MGH-HPS (Bottom graphs for each individual latent subtype).

4.3. Clinical relevance

therapeutic target, possibly treating these comorbidity symptoms or
other differences could reduce BFRB severity.
Based on these data, one could perhaps imagine formulating
different treatment plans based on the subgroups of BFRB. For example,
those individuals who fit Subtypes 1 and 2 might benefit from learning
to increase awareness through either habit reversal training or aware
ness enhancement devices, whereas those individuals with TTM who fit
into Subtype 3 might benefit from psychotherapy or pharmacotherapy
focusing on emotional dysregulation. Similarly, those with SPD who fit
into Subtype 1 may benefit from interventions that focus on enhancing
coping skills/resilience, ADHD, mood or personality (perfectionism),
and perhaps may benefit from a medication targeting mood or perfec
tionism for their BFRB.
Neurocognitive deficits have been demonstrated in patients with
TTM and SPD in the literature, compared to controls. Here, the classes
did not differ overall in terms of set-shifting or response inhibition

One of the possible benefits of understanding the complexity of
BFRBs is that treatment can be better tailored. In terms of psychosocial
treatments, there are several options that have shown some benefit for
BFRBs. Habit reversal training, alone or enhanced with dialectical
behavior therapy, or acceptance and commitment therapy, and
comprehensive model for behavioral treatment, to name a few, are all
associated with some benefit for BFRBs (Falkenstein et al., 2016; Woods
and Houghton, 2016). To a lesser extent (in terms of their being fewer
studies evaluating such treatments), but with a similar limited efficacy,
pharmacotherapy (e.g., clomipramine, olanzapine, and N-acetyl
cysteine) has shown some benefit for BFRBs as well (Rothbart et al.,
2013). The question of whether there is a subgroup of BFRB which
preferentially benefits from a particular therapy or medication, how
ever, has not been answered. Instead of considering the BFRB the
607
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Fig. 2. Profiles of latent subtypes on the MIDAS (Milwaukee Inventory for the Dimensions of Skin Picking) and (SPS-R) Skin Picking Scale Revised.

performance. It is important to note that, due to the statistical methods
used, the control group for the TTM subtypes included SPD cases; and
that the control group for the SPD subtypes included TTM cases (as
people with picking would answer “no” to all questions about pulling
and vice versa). Hence, failure to detect group differences on cognition
does not indicate that TTM and SPD as disorders are free from such
deficits; rather, just that they are not detectable when groups are defined
using the current statistical methodology. It would be valuable in future
work to explore cognition in more detail, including in comparison to
healthy control reference group(s); and to examine whether TTM/SPD
subtypes can be identified based on cognition and imaging markers. At
the same time, group differences were found in terms of Barratt
Impulsivity Scale scores. This may suggest that self-report measures may
be more sensitive to differences in such latent subtypes than these
neurocognitive tasks (prior work indicates self-report measures may link
more directly with psychopathologies than cognitive tests (Eisenberg
et al., 2019).

subclinical symptoms of the other disorder, this may complicate our
interpretation of these findings. Further, our sample size is arguably
small to estimate our mixture models, especially those with larger
number of classes. However, we did not experienced symptoms of esti
mation problems (e.g. large standard errors or unstable solutions) for
our final models. Finally, SPD classes, being mainly severity clusters may
suggest that the disorder is rather dimensional rather than categorical.
More research is needed to investigate this issue.
5. Conclusions
Although subtype characteristics have been discussed in the litera
ture and are identified in the course of clinical interviews or as part of
the functional analysis at the outset of behavioral treatment, this study is
the first to identify more definitely distinct classes of TTM and SPD,
using mixture modeling, in a large sample of patients with BFRBs and
controls. It also highlights aspects of subtyping that over the years may
have been discussed but these data would not support as meaningful (i.e.
where the person picks/pulls from; early or late onset, etc). Instead of
those numerous possible subtypes in the previous literature, we found
evidence for three distinct classes of TTM cases; and arguably two
distinct classes of SPD cases. These classes differed remarkably on
clinical characteristics and this information may be useful in future to
help direct tailored treatments and for further work into discerning the
biological underpinnings of these under-studied disorders.

4.4. Limitations
Though this is the largest analysis of potential BFRB subtypes to date,
and one of very few studies using mixture modeling in these disorders,
several limitations should be considered. The identification of differ
ences between classes could be viewed as conservative, since we first
conducted statistical tests to determine if classes differed overall;
whereas some classes might be expected to be similar rather than
different on a given measure. Given the small sample of comorbid TTM
and SPD participants, as well as the fact that some participants had
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Table 3
Differences in variables of interest across Trichotillomania (TTM) subtypes.
Variable

Class 1 TTMAbsent/
Controls (n =
121)

TTM
Subtype 1
(n = 27)

TTM
Subtype 2
(n = 81)

TTM
Subtype 3
(n = 50)

Statistic – Overall

Chi-square = 2.769; df
= 3 p = 0.429
(corrected p value = 1)
Chi-square = 0.857; df
= 3; p = .836
(corrected p value = 1)
Chi-square = 0.909; df
= 3; p = 0.823
(corrected p value = 1)
Chi-square = 16.244;
df = 3; p = .001
(corrected p value =
.013)
Chi-square = 29.705;
df = 3; p < .001
(corrected p value <
.001)
Chi-square = 24.298;
df = 3; p < .001
(corrected p value <
.001)
Chi-square = 6.117; df
= 3; p = .106
(corrected p value = 1)
Chi-square = 4.577; df
= 3; p = .206
(corrected p value = 1)
Chi-square = 36.509;
df = 3; p < .001
(corrected p value <
.001)
Chi-square = 24.303;
df = 3; p < .001
(corrected p value <
.001)
Chi-square = 19.468;
df = 3; p < .001
(corrected p value =
.003)

Post hoc tests

Demographics and Clinical Measures
Age, yrs

30.588 (0.95)

33.136
(2.288)

29.186
(1.041)

30.37
(1.452)

Sex, proportion females

0.846

0.885

0.815

80.1

Duration of illness, yrs

18.27 (1.426)

19.258
(2.33)

17.119
(1.211)

17.271
(1.592)

ADHD symptoms (Adult
ADHD Self-Report Scale
Screener total scores)

1.359 (0.149)

1.652
(0.339)

2.232
(0.215)

2.302
(0.268)

Impairment due to BFRB
(Sheehan Disability Scale
total score)

4.389 (0.515)

7.54 (1.434)

7.059
(0.789)

10.776
(1.159)

Short Mood and Feelings
Questionnaire

3.599 (0.386)

6.684
(1.104)

5.111
(0.599)

7.783
(0.872)

The Emotion Regulation
Questionnaire –
Reappraisal Subscale
Suppression Subscale

28.112 (0.652)

26.062
(1.471)

28.068
(0.776)

25.337
(1.118)

12.891 (0.473)

14.846
(1.05))

13.197
(0.574)

14.283
(0.746)

Distress Tolerance Scale
total score

56.685 (1.129)

51.615
(2.816)

52.919
(1.46)

43.629
(1.852)

Adult sensory profile:
Sensory Sensitivity
subscale

30.749 (0.701)

37.684
(1.808)

34.189
(0.966)

36.063
(1.278)

Perfectionism (Frost
Perfectionism in Adults
total score)

80.011 (1.961)

80.032
(4.274)

84.746
(2.464)

95.562
(3.047)

0.017

0

0

0.061

0.017

0.074

0.037

0.141

0.0125

0

0.037

0.020

Family history of Alcohol use
disorder, proportion with

0.182

0.146

0.178

0.213

Family history of Substance
use disorder, proportion
with
Cognitive Measures
Barratt Impulsivity Scale
total

0.074

0.073

0.099

0.142

56.12 (1.103)

58.593
(2.398)

59.935
(1.266)

64.282
(1.613)

Extra-dimensional setshifting errors

9.491 (0.963)

12.719
(2.32)

9.874
(1.225)

10.18
(1.653)

Stop-signal reaction times

207.762
(6.387)

239.64
(30.529)

220.784
(11.386)

247.528
(25.006)

Comorbidity
ADHD diagnosis, proportion
meeting diagnostic criteria
Obsessive Compulsive
Disorder (OCD) diagnosis,
proportion with diagnosis
Family History
Family History of OCD,
proportion with

Subtype
Subtype
Subtype
Subtype
Subtype
Subtype
Subtype
Subtype

1 compared to controls (p = .039)
2 compared to controls (p = .005)
3 compared to controls (p < .001)
3 compared to subtype 2 (p = .008)
1 compared to controls (p = .008)
2 compared to controls (p = .034)
3 compared to controls (p < .001)
3 compared to subtype 2 (p = .012)

Subtype 3 compared to controls (p < .001)
compared to Subtype 1 (p = .018) and compared
to Subtype 2 (p < .001) Subtype 2 compared to
controls (p = .041)
Subtype 1 compared to controls (p < .001)
Subtype 2 compared to controls (p = .004)
Subtype 3 compared to controls (p < .001)
Subtype 3 compared to controls (p < .001)
compared to Subtype 1 (p = .003) and compared
to Subtype 2 (p = .006)

Chi-square = 5.082; df
= 3; p = .166
(corrected p value = 1)
Chi-square = 6.890; df
= 3; p = .075
(corrected p value =
.830)
Chi-square = 7.198; df
= 3; p = .066
(corrected p value =
.790)
Chi-square = 0.422; df
= 3; p = .936
(corrected p value = 1)
Chi-square = 1.461; df
= 3; p = .691
(corrected p value = 1)
Chi-square = 18.097;
df = 3; p < .001
(corrected p value =
.006)
Chi-square = 1.674; df
= 3; p = .643
(corrected p value = 1)
Chi-square = 3.801; df
= 3; p = 1 (corrected p
value = 1)

Values are Mean (±SE) unless stated otherwise; only significant results are displayed under post-hoc tests.
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Subtype 2 compared to controls (p = .001) and
Subtype 3 compared to controls (p = .003)

Subtype 3 compared to controls (p < .001),
compared to Subtype 1 (p = .049) and compared
to subtype 2 (p = .034) Subtype 2 compared to
controls (p = 0.023)
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Table 4
Differences in variables of interest across skin picking disorder (SPD) subtypes.
Variable

Class 1 SPDAbsent/Controls
(n = 115)

SPD Subtype
1 (n = 112)

SPD Subtype
2 (n = 52)

Statistic – Overall

Age, yrs

29.78 (0.937)

30.244
(0.967)

32.1 (1.644)

Sex, proportion female

0.816

0.840

0.856

Duration of illness, yrs

17.557 (1.452)

17.821
(1.103)

18.095 (1.7)

ADHD symptoms (Adult ADHD
Self-Report Scale Screener total
scores)
Impairment due to BFRB (Sheehan
Disability Scale total score)

1.149 (0.142)

2.478 (0.182)

1.834 (0.257)

3.861 (0.482)

9.817 (0.741)

5.706 (0.932)

Short Mood and Feelings
Questionnaire

3.345 (0.386)

7.221 (0.578)

4.651 (0.696)

The Emotion Regulation
Questionnaire – Reappraisal
Subscale
Suppression Subscales

28.727 (0.672)

26.158
(0.707)

26.748
(1.052)

12.82 (0.495)

13.742 (0.5)

13.846
(0.745)

Distress Tolerance Scale total
score

56.37 (1.205)

48.566
(1.334)

51.701
(1.932)

Adult Sensory Profile: Sensory
Sensitivity subscale

30.043 (0.704)

36.933
(0.816)

32.874 (1.22)

Perfectionism (Frost Perfectionism
in Adults total score)

78.104 (2.027)

90.544
(2.132)

83.618
(3.028)

Chi-square = 1.51; df = 2; p
= 0.47 (corrected p value =
1)
Chi-square = 0.460; df = 2;
P = 0.795 (corrected p value
= 1)
Chi-square = 0.058; df = 2;
P = 0.971 (corrected p value
= 1)
Chi-square = 33.606; df = 2;
p < .001 (corrected p value
< .001)
Chi-square = 45.364; df = 2;
p < .001 (corrected p value
< .001)
Chi-square = 31.116; df = 2;
p < .001 (corrected p value
< .001)
Chi-square = 7.359; df = 2;
p = .025 (corrected p value
= .303)
Chi-square = 2.191; df = 2;
p = .334 (corrected p value
= 1)
Chi-square = 19.135; df = 2;
p < .001 (corrected p value
< .001)
Chi-square = 40.862 df = 2;
p < .001 (corrected p value
< .001)
Chi-square = 17.894 df = 2;
p < .001 (corrected p value
= .002)

0

0.044

0

Obsessive Compulsive Disorder
(OCD) diagnosis, proportion
with diagnosis
Family History
Family History of OCD, proportion
with

0.035

0.080

0.019

0.009

0.035

0.039

Family history of Alcohol use
disorder, proportion with

0.122

0.248

0.196

Family history of Substance use
disorder, proportion with

0.061

0.124

0.098

56.773 (1.139)

61.51 (1.08)

57.582
(1.641)

Extra-dimensional set-shifting
errors

10.674 (1.044)

9.063 (0.999)

10.46 (1.549)

Stop-signal reaction times

232.344 (12.414)

218.942
(9.266)

200.741
(8.157)

Post hoc tests

Demographic and Clinical Measures

Comorbidity
ADHD diagnosis, proportion
meeting diagnostic criteria

Cognitive Measures
Barratt Impulsivity Scale total

Subtype 1 compared to controls (p < .001) and
compared to subtype 2 (p = .041) Subtype 2
compared to controls (p = .02)
Subtype 1 compared to controls (p < .001) and
compared to Subtype 2 (p = .001)
Subtype 1 compared to controls (p < .001) and
compared to Subtype 2 (p = .005)

Subtype 1 compared to controls (p < .001)
Subtype 2 compared to controls (p = .04)
Subtype 1 compared to controls (p < .001) and
compared to Subtype 2 (p = .006) Subtype 2
compared to controls (p = .044)
Subtype 1 compared to controls (p < .001)

Chi-square = 5.193 df = 2; p
= .075 (corrected p value =
.745)
Chi-square = 3.588 df = 2; p
= .166 (corrected p value =
1)
Chi-square = 2.685 df = 2; p
= .261 (corrected p value =
1)
Chi-square = 6.387 df = 2; p
= .041 (corrected p value =
.451)
Chi-square = 2.832; df = 3;
p = .243 (corrected p value
= 1)

Funding/support

Chi-square = 9.96 df = 2; p
= 0.007 (corrected p value
= .089)
Chi-square = 1.377 df = 2; p
= .502 (corrected p value =
1)
Chi-square = 5.094 df = 2; p
= .078 (corrected p value =
.745)

the study; collection, management, analysis, and interpretation of the
data; preparation, review, or approval of the manuscript; and decision to
submit the manuscript for publication. This study was completed with
support from the REDCap project at the University of Chicago, which is
hosted and managed by the Center for Research Informatics and funded
by the Biological Sciences Division and by the Institute for Translational
Medicine, CTSA grant number UL1 TR000430 from the National In
stitutes of Health. Dr. Chamberlain’s research work is funded by a

This study was funded by the Body-Focused Precision Medicine
Initiative granted by The TLC Foundation for Body-Focused Repetitive
Behaviors to University of Chicago (Dr. Grant), Massachusetts General
Hospital (MGH)/Harvard (Dr. Keuthen), and University of California,
Los Angeles (UCLA) (Dr. Piacentini). The TLC Foundation for BodyFocused Repetitive Behaviors had no role in the design and conduct of
610

J.E. Grant et al.

Journal of Psychiatric Research 137 (2021) 603–612

Wellcome Trust Clinical Fellowship (United Kingdom; reference
110049/Z/15/Z).

5-point scale ranging from 0 (none) to 4 (extreme).
MIST-A-R questions: 1. Pull when concentrating on other activities;
2. Pulling when thinking of something else; 3. Thoughts of pulling before
pulling 4. I use something other than my fingers to pull 5. I pull while
looking in mirror; 6. I am usually not aware of my pulling; 7. Pull when
anxious or upset; 8. I intentionally start pulling; 9. Pull when having
negative emotions; 10. Don’t notice I have pulled until after; 11. Pull
because of something happening that day; 12. Pull to get rid of an un
pleasant feeling/thought; 13. Pull to control my feelings.
MGH-HPS questions: 1. Frequency of urges; 2. Intensity of urges; 3.
Ability to control urges; 4. Frequency of pulling; 5. Attempts to resist
pulling; 6. Control over pulling; 7. Associated distress.
Responses are color-coded by ordinal response (red = 0, yellowgreen = 1, green = 2, blue = 3, magenta = 4). All items for the MIDAS
and the SPS-R are rated on a 5-point scale ranging from 0 (none) to 4
(extreme).
Abbreviations: MIDAS = Milwaukee Inventory for the Dimensions of
Skin Picking SPS-R=Skin Picking Scale-Revised.
MIDAS questions: 1. Pick when having negative emotions; 2. Pick
because of something happening that day; 3. I intentionally start pick
ing; 4. I have a strange sensation before I pick; 5. I pick when thinking
about something else; 6. I pick while looking in the mirror; 7. Pick when
anxious or upset; 8. Don’t notice I am picking while doing it; 9. Pick
when concentrating on another activity; 10. I have a trance-like state
when picking; 11. I have intense urges to pick; 12. Don’t notice I have
picked until after.
SPS-R questions: 1. Frequency of urges; 2. Intensity of urges; 3. Time
spent picking; 4. Ability to control urges; 5. Level of distress; 6. Psy
chosocial interference due to picking; 7. Avoidance of other activities
due to picking; 8. Degree of skin damage.
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